Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04514016 · ClinicalTrials.gov registry record

Cross Sectional CFAR HIV/COVID-19 Study

A clinical trial, sponsored by University of Miami.

Completed
Registry status
64
Enrollment target

NCT04514016 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04514016 has completed, sponsored by University of Miami.

COMPLETED
Registry status
64 participants
Enrollment target

Study Summary

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2020-08-12
Est. Completion 2021-03-17

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT04514016

The ClinicalTrials.gov registry entry for NCT04514016 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04514016 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04514016 about?

NCT04514016 is a clinical study titled "Cross Sectional CFAR HIV/COVID-19 Study". The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

What is the current status of trial NCT04514016?

This trial is currently completed. The enrollment target is 64 participants. The study started on 2020-08-12. Estimated completion is 2021-03-17.

Who is sponsoring clinical trial NCT04514016?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.